Navigation Links
GenWay Biotech extends the You Test You program overseas
Date:3/18/2010

(San Diego, CA) March 18, 2010 GenWay Biotech, Inc., (www.genwaybio.com) the US-based diagnostic company that recently launched the You Test YouTM Cancer Assessment is expanding this cancer testing program internationally. An agreement has been executed to offer the You Test YouTM Cancer Assessment in Greece starting in April. Additional agreements are in progress for other European nations as well. GenWay currently offers this test in the United States and Canada.

Dr. Sergey Sikora, Vice President of Business Development, said, "The agreement with Greece is one of many on the horizon which will make the You Test You cancer testing service readily available to many countries worldwide that are interested in revolutionizing healthcare and facilitating self-testing for cancer."

The You Test YouTM Cancer Assessment is a unique program that enables consumers to directly access a cancer testing service without having to make an appointment with their own doctor. The You Test You platform is designed to empower consumers to be proactive about their health and their risk of having cancer. The test measures biomarkers associated with numerous types of cancer and aids in the early detection of cancer.

Early detection of cancer is the key to fighting cancer successfully. Extending this program to other countries could bring them to a higher level of healthcare with individuals being able to self-monitor themselves for diseases such as cancer.


'/>"/>

Contact: Jill Dombrauckas, PhD
jdom@genwaybio.com
858-458-0866 x119
GenWay Biotech
Source:Eurekalert

Page: 1

Related biology news :

1. GenWay Biotechs You Test You puts early cancer detection tool in the hands of consumers
2. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
3. General tumor marker test now offered by GenWay clinical laboratory
4. GenWay Biotech obtains exclusive rights to AMDLs DR-70 cancer test in US and Canada
5. New biotech advance to add heart healthy omega-3s to US diet
6. McGill, Quebec biotech firm partner for new bone-disease treatment
7. New edition of ASM Press biotechnology text announced
8. Biotech, nanotech and synthetic biology roles in future food supply explored
9. Tarantula venom-based MD therapy to be advanced by UB scientists biotech company
10. DoseCue(TM) Presents Positive Study Results at BioTech 2009
11. PDC Biotech GmbH Announces Close of Series A Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Jan. 18, 2017 MedNet Solutions ... supports the entire spectrum of clinical research, is ... record-breaking year for the organization in terms of ... MedNet,s eClinical products and services. The company,s exceptional ... success of iMedNet ™ ...
(Date:1/12/2017)... 2017  Trovagene, Inc. (NASDAQ: TROV ), ... announced that it has signed agreements with seven strategic ... Middle East for commercialization of ... first wave of international distribution agreements for Trovagene,s CLIA ... The initial partners will introduce Trovagene,s liquid ...
(Date:1/12/2017)... PUNE, India , January 12, 2017 A new ... - 2022," projects that the global biometric technology market is expected to generate revenue ... 2022. Continue Reading ... ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... , Feb. 16, 2017  ArmaGen, Inc., ... groundbreaking therapies to treat severe neurological disorders, today ... treated with AGT-181, the company,s investigational therapy for ... known as mucopolysaccharidosis type I, or MPS I). ... proof-of-concept (POC) study, presented today at the 13 ...
(Date:2/16/2017)... February 16, 2017 Patient ... of innovative telemedicine application, new and leading edge ... experiencing a boom worldwide. The healthcare sector as ... technologies, services and new therapies for companies such ... RHT), Cellectar Biosciences, Inc. (NASDAQ: CLRB ...
(Date:2/16/2017)... (PRWEB) , ... February 16, 2017 , ... ... cervical case. Dr. Kingsley Chin, professor and Harvard trained surgeon, completed the procedure ... was performed on a 55-year-old practicing female physician suffering from degenerative disc disease ...
(Date:2/16/2017)... , ... February 16, 2017 ... ... Molecular Research Inc. has further extended its industry leading Biochemistry Services specifically ... offers state-of-the-art cGMP techniques and methods for the biochemical and biosimilar ...
Breaking Biology Technology: